| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-15 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-14 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-12 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-11 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-10 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |